Pharmacokinetics of Levodopa in Patients With Parkinson's Disease Treated With Levodopa/Carbidopa Infusion With and Without Oral COMT Inhibitors.

Trial Profile

Pharmacokinetics of Levodopa in Patients With Parkinson's Disease Treated With Levodopa/Carbidopa Infusion With and Without Oral COMT Inhibitors.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Levodopa/carbidopa (Primary) ; Entacapone; Tolcapone
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Most Recent Events

    • 20 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jan 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
    • 01 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top